Review
Aug 2026
Antithrombotic therapy to minimize total events after ACS or PCI in atrial fibrillation: insights from AUGUSTUS.
For patients with AF after ACS or PCI, DOAC-based dual antithrombotic therapy provides the most favorable cumulative safety-efficacy balance, and future research should focus on the timing of aspirin discontinuation and validate recurrent-event endpoints.
Seung-Hun Lee, Jennifer A. Rymer, W. S. Jones
· Current Opinion in Cardiolog... · 0 citations